Key Market Indicators
**Japanese Insulin Import Decline Forecasted** Japan's insulin import is projected to decrease from approximately $344 million in 2023 to around $312 million by 2028. This represents a year-on-year compound annual growth rate (CAGR) decline of 1.7%. Historical data since 1993 indicates a consistent annual decrease in demand, averaging 2.4% per year. **Insulin Export on the Rise Despite Historical Decline** Conversely, Japan's insulin exports are expected to increase from about $155,000 in 2023 to nearly $184,000 by 2028. This growth translates to an average annual growth rate of 2.6%, despite a historical yearly decline of 21.4% since 2000. **Global Rankings and Competitors** In 2023, Japan ranked 32nd in insulin exports, with Morocco slightly ahead at the same value of $155,000. Leading the global rankings were France, Italy, and China, occupying the second, third, and fourth positions respectively.
